Baseline demographic and disease characteristics (including sex, age, BCLC stage, Eastern Cooperative Oncology Group score, presence of cirrhosis, severity of liver disease if cirrhotic, ferritin, AFP level at diagnosis, therapy received) were similar between the two groups (table 1). This evidence concerns the gene AFP and liver disorder.